Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Time to buy….enough said

<< Previous

Bullboard Posts

Next >>

Comment by fox7mfon Oct 14, 2023 9:25am

198 Views

Post# 35683540

RE:Time to buy….enough said

This situation is dire. Coffey has failed in his responsibility to shareholders. He should be relegated to the science end and removed from any BD responsibilities. Oncy is going to go into '24 well under $5 and that is criminal. EOM.

<< Previous

Bullboard Posts

Next >>

Crypto and blockchain stock ends year with a profit